Giusy Tiseo
University of Pisa(IT)Azienda Ospedaliera Universitaria Pisana(IT)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Antibiotics Pharmacokinetics and Efficacy, COVID-19 Clinical Research Studies, Pneumonia and Respiratory Infections
Most-Cited Works
- → Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales(2020)349 cited
- → Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study(2021)255 cited
- → Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae(2020)224 cited
- → JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality(2020)215 cited
- → Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii(2022)181 cited
- → Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study(2020)171 cited
- → Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study(2020)154 cited
- → Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study(2021)147 cited
- → Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)(2023)143 cited
- → Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients(2020)130 cited